Jobs
-
Acorda Therapeutics has announced that it received a $1.4 million grant from the Bill & Melinda Gates Foundation for development of a dry powder lung surfactant for the treatment of neonatal respiratory distress syndrome (RDS)… Read more . . .
-
Propeller Health has received 510(k) clearance from the FDA to market the Propeller inhaler monitoring platform for use with the Diskus DPI and with the Respimat SMI, the company announced. Two versions of the Propeller… Read more . . .
-
The FDA has approved Amneal Pharmaceuticals’s generic version of Tobi tobramycin inhalation solution, the company said. The product is the New Jersey-based generic pharmaceutical company’s first inhalation solution. Amneal co-CEO and Chairman Chirag Patel said,… Read more . . .
-
Theravance, Inc. has hired former Wells Fargo Securities Senior Pharmaceuticals Equity Research Analyst Michael E. Faerm as Senior VP and Chief Business Officer, the company announced. Theravance President and CEO Michael W. Aguiar said, “Michael… Read more . . .
-
Swedish-based Inhalation Sciences AB (ISAB) has added new minority shareholders Stockholms Affärsänglar (STOAF) and Almi Invest, “with a significant initial capital investment,” the company said. According to ISAB, that investment is the first phase out… Read more . . .
-
OptiNose has announced that a study comparing OPN-300 intranasal oxytocin to intravenous oxytocin for the treatment of autism showed the achievement of similar blood levels but significantly greater social-cognitive effects after intranasal administration. The results… Read more . . .
-
A study published July 13, 2015 in the Journal of Clinical investigation demonstrated that an inhaled vaccine created by a team from The University of Texas Medical Branch at Galveston (UTMB) and the National Institutes… Read more . . .
-
Device manufacturer Gerresheimer reported a 6.3% increase in revenues and a 7.4% increase in net income in the second quarter of 2015, crediting “very strong growth” in medical plastic products such as inhalers. According to… Read more . . .
-
Moerae Matrix, which is developing inhaled therapies for the treatment of idiopathic pulmonary fibrosis and other lung diseases, has announced the appointment of Bill Bradford as Chief Medical Officer. Bradford was most recently a Senior… Read more . . .
-
The FDA has issued product-specific recommendations for demonstrating the bioequivalence of over 40 drug products, including several OINDPs. The newly added documents include guidances for azelastine HCL/fluticasone propionate nasal spray, budesonide/formoterol fumarate MDI, and levalbuterol… Read more . . .
Upcoming Events
Sponsored by Intertek
Want information about upcoming OINDP-related events delivered directly to your inbox? click here
May 10-May 14: RDD 2026, Phoenix, AZ, USA
May 15-May 16: ATS Respiratory Innovation Summit 2026, Orlando, FL, USA
May 17-May 20: ATS International Conference 2026, Orlando, FL, USA
June 9-June 10: Nasal Drug Delivery Symposium: Current Status and Future Opportunities, Stockholm, Sweden
June 10: SMI.London 2026, London, UK